Skip to main content

Advertisement

Log in

Serum prolidase activity and oxidative stress in patients with pseudoexfoliation syndrome

  • Glaucoma
  • Published:
Graefe's Archive for Clinical and Experimental Ophthalmology Aims and scope Submit manuscript

Abstract

Purpose

We aimed to evaluate the serum prolidase activity (SPA), malondialdehyde (MDA), and catalase levels in patients with pseudoexfoliation (PEX) syndrome.

Method

Thirty-four patients with PEX syndrome and thirty-eight age- and gender-matched healthy subjects were included in this prospective clinical study. Each participant underwent full ophthalmologic examination. The SPA, serum MDA, and catalase levels were measured and compared between the patients with PEX syndrome and healthy subjects.

Results

The SPA was significantly lower in patients with PEX syndrome compared to healthy controls (14.1 ± 7.1 vs. 30.1 ± 4.3 ng/ml; p = 0.001). The mean serum MDA values the of PEX syndrome and control groups were comparable (28.7 ± 5.7 vs. 30.4 ± 5.3 nmol/ml, respectively; p = 0.185). The mean serum catalase level tended to be lower in the PEX group compared to healthy controls (0.12 ± 0.02 vs. 0.21 ± 0.05 k/ml, respectively; p = 0.077).

Conclusion

Our findings suggest that the SPA was significantly lower in patients with PEX syndrome compared to healthy controls. Thus, prolidase may have a role in the pathogenesis of the PEX syndrome.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Schlötz-Schrehardt UM, Koca MR, Naumann GOH, Volkholz H (1992) Pseudoexfoliation syndrome: ocular manifestation of a systemic disorder? Arch Ophthalmol 110:1752–1756

    Article  Google Scholar 

  2. Streeten BW, Li ZY, Wallace RN, Eagle RCJ, Keshegehehian AA (1992) Pseudoexfoliative fibrilliopathy in visceral organs of a patient with pseudoexfoliation syndrome. Arch Ophthalmol 110:1757–1762

    Article  CAS  PubMed  Google Scholar 

  3. Lindberg JG (1917) Clinical studies of depigmentation of the pupillary margin and transillumination of the iris in case of senil cataract and also in normal eyes in the aged. Diss Helsingfors Univ

  4. Naumann G, Schlötzer-Schrehardt U, Küchle M (1998) Pseudoexfoliation syndrome for the comprehensive ophthalmologist. Intraocular and systemic manifestations. Ophthalmol 105:951–968

    Article  CAS  Google Scholar 

  5. Ritch R (2001) Exfoliation syndrome. Curr Opin Ophthalmol 12:124–130

    Article  CAS  PubMed  Google Scholar 

  6. Ritch R (2014) Ocular and systemic manifestation of exfoliation syndrome. J Glaucoma 23:1–8

    Article  PubMed  Google Scholar 

  7. Yüksel N, Karabaş VL, Arslan A, Demirci A, Çağlar Y (2001) Ocular hemodynamics in pseudoexfoliation syndrome and pseudoexfoliation glaucoma. Ophthalmology 108:1043–1049

    Article  PubMed  Google Scholar 

  8. Schlötz-Schrehardt U, Koca MR, Naumann GO (2006) Ocular and systemic pseudoexfoliation syndrome. Am J Ophthalmol 141:921–937

    Article  Google Scholar 

  9. Kusano C, Ferrari B (2008) Total antioxidant capacity: a biomarker in biomadical and nutritional studies. J Cell Mol Biol 7:1–15

    CAS  Google Scholar 

  10. Chen J, Zeng L, Xia T et al (2015) Toward a biomarker of oxidative stress: A fluorescent probe for exogenous and endogenous malondialdehyde living cells. Anal Chem 87:8052–8056

    Article  CAS  PubMed  Google Scholar 

  11. Glorieux C, Zamocky M, Sandoval JM, Verrax J, Calderon PB (2015) Regulation of catalase expression in healthy and cancerous cells. Free Radic Biol Med 87:84–97

    Article  CAS  PubMed  Google Scholar 

  12. Wu G, Bazer FW, Burghardt RC et al (2011) Prolin and hydroxyprolin metabolism: implication for animal and human nutrition. Amino Acids 40:1053–1063

    Article  CAS  PubMed  Google Scholar 

  13. Kurien BT, Patel NC, Porter AC (2006) Prolidase deficiency and the biochemical assays used in its diagnosis. Anal Biochem 349:165–175

    Article  CAS  PubMed  Google Scholar 

  14. Gartaganis SP, Georgakopoulos CD, Mela EK et al (2002) Matrix metalloproteinases and their inhibitors in exfoliation syndrome. Ophthalmic Res 34:165–171

    Article  CAS  PubMed  Google Scholar 

  15. Schlötzer-Schrehardt U, Lommatzsch J, Küchle M, Konstas AG, Naumann GO (2003) Matrix metalloproteinases and their inhibitors in aqueous humor of patients with pseudoexfoliation syndrome/glaucoma and primary open angle glaucoma. Invest Ophthalmol Vis Sci 44:1117–1125

    Article  PubMed  Google Scholar 

  16. Aebi H (1974) Catalase. In: Bergmeyer U (ed) Methods of enzymatic analysis. Academic Press, New York and London, pp 673–677

    Chapter  Google Scholar 

  17. Esterbauer H, Cheeseman KH (1990) Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. Methods Enzymol 186:407–421

    Article  CAS  PubMed  Google Scholar 

  18. Totan Y, Çekiç O, Borazan M, Uz E, Sogut S, Akyol O (2001) Plasma malondialdehyde and nitric oxide levels in age related macualar degeneration. Br J Ophtalmol 85:1426–1428

    Article  CAS  Google Scholar 

  19. Bhuyan KC, Bhuyan DK, Podos SM (1986) Lipid peroxidation in cataract of the human. Life Sci 38:1463–1471

    Article  CAS  PubMed  Google Scholar 

  20. Erdurmuş M, Yağcı R, Atış Ö, Karadağ R, Akbaş A, Hepsen IF (2011) Antioxidant status and oxidative stress in primary open angle glaucoma and pseudoexfoliative glaucoma. Curr Eye Res 36:713–718

    Article  PubMed  Google Scholar 

  21. Yagci R, Gurel A, Ersoz I et al (2006) Oxidative stress and protein oxidation in pseudoexfoliation syndrome. Curr Eye Res 31:1029–1032

    Article  CAS  PubMed  Google Scholar 

  22. Koliakos GG, Befani CD, Mikropoulos D, Ziakas NG, Konstas AG (2008) Prooxidant antioxidant balance, peroxide and catalase activity in the aqueous humour and serum of patients with exfoliation syndrome or exfoliative glaucoma. Graefes Arch Clin Ophthalmol 246:1477–1483

    Article  CAS  Google Scholar 

  23. Yılmaz A, Adigüzel U, Tamer L et al (2005) Serum oxidant/antioxidant balance in exfoliation syndrome. Clin Exp Ophthalmol 33:63–66

    Article  Google Scholar 

  24. Surazynski A, Miltyk W, Palka J, Phang JM (2008) Prolidase dependent regulation of collagen biosynthesis. Amino Acids 35:731–738

    Article  CAS  PubMed  Google Scholar 

  25. Jackson SH, Dennis AW, Greenberg M (1975) Iminodipeptiduria: a genetic defect in recycling collagen: a metod for determining prolidase in erythrocytes. Can Med Assoc J 113:759–763

    CAS  PubMed  PubMed Central  Google Scholar 

  26. Määttä M, Tervahartiala T, Harju M, Airaksinen J, Autio-Harmainen H, Sorsa T (2005) Matrix metalloproteinases and their tissue inhibitors in aqueous humor of patients with primary open angle glaucoma, exfoliation syndrome, and axfoliation glaucoma. J Glaucoma 14:64–69

    Article  PubMed  Google Scholar 

  27. Verma AK, Raj J, Sharma V, Singh TB, Srivastava S, Srivastava R (2015) Plasma prolidase activity and oxidative stress with parkinson’s disease. Park Dis. doi:10.1155/2015/598028

    Google Scholar 

  28. Akçakoyun M, Pala S, Esen O et al (2010) Dilatation of the ascending aort is associated with low serum prolidase activity. Tohoku J Exp Med 220:273–277

    Article  PubMed  Google Scholar 

  29. Kıratlı H, Satılıs M (1998) Prolidase deficiency associated with pathologic myopia. Ophthalmic Genet 19:49–53

    Article  PubMed  Google Scholar 

  30. Gomes I, Xiong W, Miki T, Rosner MR (1999) A prolin and glutamin rich protein promots apoptosis in neuronal cells. J Neurochem 73:612–622

    Article  CAS  PubMed  Google Scholar 

  31. Berlau J, Lorenz P, Beck R (2001) Analysis of aqueous humour proteins of eyes with and without pseudoexfoliation syndrome. Graefes Arch Clin Exp Ophthalmol 239:743–746

    Article  CAS  PubMed  Google Scholar 

  32. Ringvold A, Husdy G (1973) Pseudoexfoliation material an amyloid like substance. Exp Eye Res 17:289–299

    Article  CAS  PubMed  Google Scholar 

  33. Ringvold A, Husdy G, Pettersen S (1989) Electrophoretic study of proteins associated with pseudoexfoliation syndrome. Acta Ophthalmol (Copenh) 67:724–726

    Article  CAS  Google Scholar 

  34. Gottanka J, Flügel-Koch C, Martus P, Johnson DH, Lütjen-Drecoll E (1997) Correlation of pseudoexfoliation material and optic nerve damage in pseudoexfoliation syndrome. Invest Ophthalmol Vis Sci 38:2435–2446

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mehmet Tetikoğlu.

Ethics declarations

Funding

No funding was received for this research.

Conflict of interest

All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers’ bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements), or non-financial interest (such as personal or professional relationships, affiliations, knowledge or beliefs) in the subject matter or materials discussed in this manuscript.

Ethical approval

The study adhered to the tenets of the Declaration of Helsinki. The Institutional Review Board of the Dumlupinar University School of Medicine approved the study protocol.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Additional information

This manuscript has not been previously published and is not under consideration for publication elsewhere. The authors do not have any financial or proprietary interest in a product, method, or material mentioned in the manuscript.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tetikoğlu, M., Sağdik, H.M., Aktas, S. et al. Serum prolidase activity and oxidative stress in patients with pseudoexfoliation syndrome. Graefes Arch Clin Exp Ophthalmol 254, 1339–1343 (2016). https://doi.org/10.1007/s00417-016-3338-6

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00417-016-3338-6

Keyword

Navigation